002317 眾生藥業
按盤價 
18.520 -1.240 (-6.275%)
18.520 -1.240 (-6.275%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 4.779 | -7.234 | 6.534 | 8.973 | 7.932 |
| 總資產報酬率 ROA (%) | 3.509 | -4.981 | 4.304 | 6.032 | 5.737 |
| 投入資產回報率 ROIC (%) | 3.937 | -5.559 | 4.798 | 6.656 | 6.283 | 邊際利潤分析 |
| 銷售毛利率 (%) | 58.067 | 56.034 | 58.596 | 64.857 | 66.796 |
| 營業利潤率 (%) | 16.662 | -11.346 | 11.443 | 13.985 | 12.872 |
| 息稅前利潤/營業總收入 (%) | 16.380 | -13.255 | 11.509 | 15.901 | 14.731 |
| 淨利潤/營業總收入 (%) | 14.220 | -15.156 | 9.573 | 11.784 | 11.308 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 95.063 | -71.135 | 111.068 | 88.538 | 105.659 |
| 價值變動淨收益/利潤總額(%) | 1.657 | -1.980 | -14.702 | 7.290 | -14.883 |
| 營業外收支淨額/利潤總額(%) | -0.376 | 16.652 | -5.314 | -1.618 | -1.029 | 償債能力分析 |
| 流動比率 (X) | 3.543 | 2.877 | 3.901 | 2.918 | 5.096 |
| 速動比率 (X) | 3.131 | 2.510 | 3.388 | 2.484 | 4.234 |
| 資產負債率 (%) | 21.522 | 27.791 | 29.927 | 33.917 | 27.822 |
| 帶息債務/全部投入資本 (%) | 8.893 | 14.226 | 10.781 | 17.491 | 11.050 |
| 股東權益/帶息債務 (%) | 968.324 | 554.749 | 696.408 | 409.311 | 698.178 |
| 股東權益/負債合計 (%) | 355.830 | 253.650 | 225.383 | 189.029 | 254.843 |
| 利息保障倍數 (X) | -74.647 | -37.051 | 17.900 | 7.436 | 7.400 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 80.412 | 73.953 | 67.718 | 66.894 | 66.378 |
| 存貨周轉天數 (天) | 132.823 | 159.599 | 166.773 | 178.616 | 191.041 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 22/09/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
